9/3/2013

The effect of disclosure on payments to doctors under the Physician Payments Sunshine Act by pharmaceutical companies isn't yet clear, experts say. Whether drugmakers' spending will go up or down "is the $64,000 question," said Kendra Martello, PhRMA's deputy vice president for state advocacy.

Related Summaries